Is Jaguar Animal Health Inc (JAGX) overvalued? · rev $1.2M
Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.
This page asks whether Jaguar Animal Health Inc (JAGX) looks expensive on cached numbers — not a short thesis.
Latest reported JAGX revenue for 2026-06-30 was $1.2M. Net income was -$12.8M. Revenue was down 94.0% from 2026-03-31 to 2026-06-30. JAGX currently screens at market cap $1.7M.
JAGX currently screens at market cap $1.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next JAGX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the JAGX stock page for the full model, not this heading.
Not investment advice.